TruthOrFake Logo
TruthOrFake
Fact Check: Nonfarm payrolls increased by 147,000 in June.

Fact Check: Nonfarm payrolls increased by 147,000 in June.

Published July 3, 2025
ByFactChecker 1.1 avatarFactChecker 1.1
✓
VERDICT
True

# Fact Check: Nonfarm Payrolls Increased by 147,000 in June ## What We Know The claim that nonfarm payrolls increased by 147,000 in June is supported...

Fact Check: Nonfarm Payrolls Increased by 147,000 in June

What We Know

The claim that nonfarm payrolls increased by 147,000 in June is supported by multiple sources. According to the Bureau of Labor Statistics, the U.S. economy added 147,000 jobs in June 2025, marking a significant increase from the previous month's upwardly revised figure of 144,000. This increase was also higher than economists' expectations, which had forecasted a rise of only 110,000 jobs for that month. The unemployment rate remained relatively stable, dipping slightly to 4.1% from 4.2% in May 2025 (Benzinga).

Additionally, NBC New York confirmed that the nonfarm payrolls indeed increased by 147,000, aligning with the BLS report. The report also highlighted that government hiring contributed significantly to this increase, with state governments adding 47,000 jobs primarily in education (RTÉ).

Analysis

The evidence supporting the claim is robust, with multiple reputable sources corroborating the figure of 147,000 new jobs added in June. The Bureau of Labor Statistics is the authoritative source for employment statistics in the U.S., making their report highly reliable. Furthermore, the data was reported by credible news outlets such as Benzinga and NBC New York, which are known for their economic reporting.

While the claim is supported by strong evidence, it is important to note that economic data can sometimes be subject to revisions. For instance, the previous month's job gains were revised upward from 139,000 to 144,000 (Benzinga). However, the consistency across multiple reports regarding the June figures suggests that the 147,000 increase is accurate and reflects a positive trend in job growth.

Conclusion

The claim that nonfarm payrolls increased by 147,000 in June is True. This conclusion is based on reliable data from the Bureau of Labor Statistics and corroborated by multiple reputable news sources. The increase not only exceeded expectations but also indicated a strengthening labor market.

Sources

  1. Google
  2. June US Jobs Report: 147,000 Rise in Payrolls, Stronger Than Expected
  3. Google Bilder
  4. June Jobs Report Beats Every Forecast Despite Bleak ADP Data - Benzinga
  5. Google Translate
  6. U.S. payrolls increased by 147,000 in June, more than expected
  7. Google Videos
  8. June US job growth beats expectations, jobless rate dips - RTÉ

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
✓100% Free
✓No Registration
✓Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: U.S. private payrolls fell by 33,000 jobs in June 2023.
True
🎯 Similar

Fact Check: U.S. private payrolls fell by 33,000 jobs in June 2023.

Detailed fact-check analysis of: U.S. private payrolls fell by 33,000 jobs in June 2023.

Jul 3, 2025
Read more →
Fact Check: U.S. private payrolls fell by 33,000 jobs in June.
Unverified
🎯 Similar

Fact Check: U.S. private payrolls fell by 33,000 jobs in June.

Detailed fact-check analysis of: U.S. private payrolls fell by 33,000 jobs in June.

Jul 3, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Shoplifting complaints in New York City increased from 40,000 in 2019 to 65,000 in 2022.
Partially True

Fact Check: Shoplifting complaints in New York City increased from 40,000 in 2019 to 65,000 in 2022.

Detailed fact-check analysis of: Shoplifting complaints in New York City increased from 40,000 in 2019 to 65,000 in 2022.

Jul 10, 2025
Read more →
Fact Check: An increased use of AI for entertainment can lead to water and power shortages.
True

Fact Check: An increased use of AI for entertainment can lead to water and power shortages.

Detailed fact-check analysis of: An increased use of AI for entertainment can lead to water and power shortages.

Aug 9, 2025
Read more →
Explore All Fact Checks